Pharmaceutical Market — Europe | NovaPharmaNews

Breaking

Cellenkos Receives FDA Clearance for CK0802 Phase 2a Trial in Steroid-Refractory GVHD FDA Approves Guardant360 CDx Companion Diagnostic for Pfizer's VEPPANU in ER+/HER2- Breast Cancer RAPS Euro Convergence 2026: Regulatory News - Day 1 Roundup

Small Molecule API Market Projected to Reach $202.53 Billion by 2036 as Generic Drug Demand Surges

NewsApr 29, 2026

Small Molecule API Market Projected to Reach $202.53 Billion by 2036 as Generic Drug Demand Surges

Small molecule API market set to hit $202.53 billion by 2036, driven by generic drug demand and oncology pipeline expansion across global markets.

Prof. Marcus Webb